Schedule 13G ownership disclosure

Forte Biosciences Inc

Common Stock · CUSIP: 34962G208

Event date: 2024-12-31

Filing-level shares
1,133,944
Percent of class
17.7%
  • Alger Associates, Inc. 13-3017981

    Shares: 1,133,944 · Class: 17.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000950170-25-021463
Form type
SCHEDULE 13G/A
Filer
ALGER ASSOCIATES INC
CIK
CIK 1000264
Filed
Feb 14, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub